Atovaquone

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Mepron (GSK); Wellvone (GSK)
  • INDICATIONS: Pneumocystis carinii infection
  • CLASS: Antimalarial, Antiprotozoal
  • HALF-LIFE: 1.5–4 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Efavirenz, Etoposide, Histamine, Hypoglycemic agents, Indinavir, Lopinavir, Metoclopramide, Rifabutin, Rifampin, Rifapentine, Ritonavir, Tetracycline, Zidovudine

PREGNANCY CATEGORY: C

Our database has 28 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
GASTROINTESTINAL/HEPATIC
NEUROMUSCULAR/SKELETAL
RESPIRATORY
OTHER


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top